Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3f70bd934769cefd55098068d640117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc4a1276167d80411d298fdebf07679b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2f2c5972365172d35633c3e715a4137 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-876 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00119 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2013-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82630f8195987b53755c4742eb2df1b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_044447aa656bc347c3cb15dee461a1d9 |
publicationDate |
2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9345755-B2 |
titleOfInvention |
Composition and methods for treating melanoma |
abstract |
The present invention encompasses novel peptides useful for preventing and treating cancer, particularly melanoma. Multiple sequences of interest are provided and these sequences have been incorporated into other peptides to obtain a series of peptides of about 30 amino acid residues in length wherein the properties of each combine to yield an effective cocktail for treating melanoma, which surpasses the use of single peptides as immunogens, as well as shorter peptides as immunogens. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10654908-B2 |
priorityDate |
2012-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |